Barclays’s BrightSpring Health Services Unit BTSGU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.38M Buy
6,039
+5,039
+504% +$925K ﹤0.01% 2596
2026
Q1
$142K Sell
1,000
-31,816
-97% -$4.3M ﹤0.01% 3876
2025
Q4
$4.14M Hold
32,816
– – ﹤0.01% 2363
2025
Q3
$3.32M Hold
32,816
– – ﹤0.01% 2499
2025
Q2
$2.71M Buy
32,816
+797
+2% +$58.9K ﹤0.01% 2610
2025
Q1
$2.08M Sell
32,019
-996
-3% -$70.4K ﹤0.01% 2601
2024
Q4
$2.07M Hold
33,015
– – ﹤0.01% 2848
2024
Q3
$1.84M Hold
33,015
– – ﹤0.01% 2917
2024
Q2
$1.55M Sell
33,015
-1,985
-6% -$88.2K ﹤0.01% 2312
2024
Q1
$1.55M Buy
+35,000
New +$1.46M ﹤0.01% 2776

Other funds holding BTSGU

Barclays's BTSGU Position: Q2 2026 in Review

Barclays increased its BrightSpring Health Services Unit (BTSGU) stake by 504% in Q2 2026, buying an estimated $925K and bringing the position to 6,039 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #2596.

Barclays first reported a position in BTSGU in Q1 2024 and has held it in 10 quarters since. The position peaked at $4.14M in Q4 2025. 28 funds tracked by Wall St. Rank hold BTSGU as of Q2 2026.

  • Barclays held 6,039 shares of BrightSpring Health Services Unit worth $1.38M as of Q2 2026.
  • Barclays bought 5,039 BrightSpring Health Services Unit shares in Q2 2026, an estimated $925K.
  • BrightSpring Health Services Unit made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #2596 holding.
  • Barclays first reported a position in BrightSpring Health Services Unit in Q1 2024 and has held it in 10 quarters since.
  • Barclays's BrightSpring Health Services Unit position peaked at $4.14M in Q4 2025.
  • 28 funds tracked by Wall St. Rank held BrightSpring Health Services Unit as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.